presentation of industrial pharmacy 2

41
Process validation of Sterilization & Water Process Systems

Upload: malla-reddy-college-of-pharmacy

Post on 05-Jul-2015

127 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: Presentation  of industrial pharmacy 2

Process validation of Sterilization& Water Process Systems

Page 2: Presentation  of industrial pharmacy 2

STERILIZATION VALIDATION

• Sterile products have several unique properties such as

1. Free from micro organisms

2. Free from pyrogens

3. Free from particulates

4. High standards of purity and quality

References: [1,2,3, & 4]

Page 3: Presentation  of industrial pharmacy 2

Methods of sterilization of products

HEAT:-1. Moist heat-auto clave2. Dry heat-hot air oven GAS:-1. ethylene oxide2. Peracetic acid3. Hydrogen peroxide(vapor phase)4. Chlorine di oxide

References: [5& 6]

Page 4: Presentation  of industrial pharmacy 2

Radiation

1. Gamma rays

2. Beta rays

3. Ultraviolet

4. Microwave

References: [5& 6]

Page 5: Presentation  of industrial pharmacy 2

Validation of steam sterilization cyclesQualification and calibration 1. Mechanically checking ,upgrading, and qualifying the

sterilizer unit

Page 6: Presentation  of industrial pharmacy 2

Selection and calibration of thermocouples• Cu constantan wires coated with teflon are a popular choice as

thermocouple monitors

• Accuracy of thermocouples should be ±0.5°C. Temperature accuracy is especially important in steam sterilization validation.

• Thermocouple accuracy is determined using NATIONAL BUREAU OF STANDARDS (NBS) traceable constant temperature calibration instruments.

• Thermocouples should be calibrated before and after validation experiment at 2 temperatures i.e. 0C & 125 C .

• New thermocouple-recording devices are capable of automatically correcting temperature

• Any thermocouple that senses a temperature of more than 0.5 C away from the calibration temperature bath should be discarded

• Temperature recorders should be capable of printing temperature data in 0.1°C increments

References: [8 & 9]

Page 7: Presentation  of industrial pharmacy 2

Selection & calibration of BI• The organism most resistant to steam heat is the

bacterial spore B. stearothermophilus. This bacterialspore is commonly used BI’s in validating steamsterilization cycles.

• Spore trips or spore suspensions are used in thevalidation studies. the no. of mo’s per ml of suspensionmust be as accurately known as D value.

• Precautions should be taken to use proper storageconditions for B. stearothermophilus BIs .storing in thefreezer provides a more stable resistance profile for theshelf life of the indicator.

References: [7 ]

Page 8: Presentation  of industrial pharmacy 2

Heat distribution studiesIt include 2 phases1. Heat distribution in any empty autoclave chamber.2. Heat distribution in a loaded autoclave chamber.a. 10-20 thermocouples should be used/cycle. thermocouples

should be secured inside the chamber.b. The trips where the wires are soldered should not make contact

with the autoclave interior walls or any metal surface.c. 1 end of thermocouple should remain in an ice bath and high

temperature oil bath during each cycle for reference when thetemp monitoring equipement has the capability for electronicallycompensating each temp measurement against an internalreference.

d. Heat distribution studies following the initial study may employfewer thermocouples as the cool spot in the chamber & in theload is identified.

e. The difference in temp b/n the coolest spot $ the mean chambertemperature should not be greater than 2.5C.

References: [8 ]

Page 9: Presentation  of industrial pharmacy 2

Heat penetration studies• This is the most critical component of the entire validation

process• Thermocouples will be placed both inside and outside the

container at the coolspot location(s) in the steam exhaustline and in constant temperature baths outside thechamber

• The sterilization cycle design must be based on the heatingcharecteristics of the load and containers located in theslowest heating zone of the load.

• The variation in the rate of heating of the slowest heatingzone must be known, so this variation must be determinedunder fully loaded conditions

• The effect of load to load variation on the time-temperature profile must also be determined.

• Then the statistically worst case conditions should be usedin the final sterilization process design

Page 10: Presentation  of industrial pharmacy 2

• The final step in steam sterilization process theestablishment of a monitoring program to ensurethat the validated cycle remains essentiallyunchanged in the future.

• Cycle monitoring usually involves the use ofthermocouples to measure heat penetration at thecool spot location.

• Any changes in the load size, load configuration, orcontainer charecteristics (volume, geometry etc)must be accompanied by repeat validation studies toprove that the cool spot location has not changed

References: [10 ]

Page 11: Presentation  of industrial pharmacy 2

Validation of dry-heat sterilization cycles

1. Batch oven validation

• Air balance determination in an empty oven data are obtained on the flow rates of both intake and exhaust air. air should be balanced so that positive pressure is exerted to the non sterile side when the door is opend and air velocity across and up and down the opening of the door is ±50 FPM of the average velocity

Page 12: Presentation  of industrial pharmacy 2

• Heat distribution of an empty chamber thermocouples should be situated according to a specific predetermined pattern. Repeatability of temp attainment and identification of cold spot can be achieved if the temp range is ±15°C at all monitored locations.

• Heat penetration studies. These studies should be designed to determine the location of slowest heating point within a commodity at various locations of test load in sterilizer.

• Mechanical repeatability. during all these studies mechanical repeatability in terms of air velocity, temp consistency, reliability and sensitivity of all the oven and instrumental controls must be verified.

References: [11 ]

Page 13: Presentation  of industrial pharmacy 2

2.Tunnel sterilizer validation Air balance determination• Proper air balance is more critical to a tunnel sterile

process than a batch oven process .since the items being sterilized are exposed to a different air systems(eg:-heating zone $ cooling zone).in the absence of a critical balance of air dynamics, either the items will not be cooled sufficiently once they exit the tunnel or they will be cooled too quickly. causing the glass to shatter and contaminate the entire tunnel area with particles.

• The major problem in validating tunnel sterilizers is the control of particules. not only are items exposed to great extreams in temp, but also the conveyer belt is a natural source of particulates because metal is moving against metal.

• Air must be particulate-free as it enters the tunnel area; therefore, all high efficiency particulate air(HEPA)filters in the tunnel must be tested and certified prior to validation studies.

Page 14: Presentation  of industrial pharmacy 2

Heat distribution studies• Thermocouples used in tunnel sterilizer validation

must be sufficiently durable to withstand the extremely high( ≥ 300 c)temperatures in the heating zone area of the tunnel heat-distribution studies should determine where the cold spots are located as a function of the width of the belt $ height of the tunnel chamber. trays or tracks of ampules are vials should run through the tunnel

• Bottle-mapping studies may also be conducted during this phase. the purpose of these studies is to determine possible locations inside the container that are most difficult to heat.

References: [12 ]

Page 15: Presentation  of industrial pharmacy 2

Heat penetration studies• For testing of the tunnel sterilization, heat-penetration

studies must be completed in order to identify the coolest container in the entire load. Results of heat-distribution studies should aid in the predicting where the coolest location with in the load should be. Thermocouples should be diposited at or near the coolest point inside the container from bottle-mapping studies.

• The containers inner surface should be in contact with the thermocouple tip because the objective is to sterilize the inner walls of the container, as well as the inner space.

• Every loading should be done using 10-20 thermocouples distributed through out the load.

References: [ 9 ]

Page 16: Presentation  of industrial pharmacy 2

Mechanical repeatability

• Air velocity, air particulates, temp consistency and reliability of all the tunnel controls(heat zone temperatures, belt speed, and blower functions)must be proved during the physical validation studies.

References: [ 9 ]

Page 17: Presentation  of industrial pharmacy 2

3.Biological process validation of dry heat sterilization cycles

• mo’s known to be most resistant to dry heat must be used toprove the ability of dry heat cycle to destroy them at thecoolest location in load. the dry heat process is claimed toproduce both sterile and pyrogen-free commodities, validationstudies must be done using both mo’s $ microbial endotoxins.

• Biological validation of dry heat cycles should be based on thedestruction of endotoxin rather than on the destruction ofmo’s because of the enormous dry heat resistance ofendotoxin compared to mo’s.

• With both mo’s $ endotoxin challenges, the cool spotidentified in heat distribution $ the heat penetration studieswill be the logical location to run the microbial challenge tests.containers inoculated with the microbial cells or endotoxin willbe situated adjacent to identical containers into whichthermocouples are secured to monitor temp. References: [ 9 ]

Page 18: Presentation  of industrial pharmacy 2

Step by step sequence in the microbial validation of a dry heat process for sterilizing and depyrogenating large volume

glass containers by wegel $ akers et al

1. Place spore carrier in approximately 12 glass bottles located at thecoolest area of the oven. bottles adjucent to the inoculated bottlesshould contain thermocouples for the monitoring purposes .

2. Run a complete cycle using the desired loading pattern for futuredry heat overkill cycles.

3. After the cycle, aseptically transfer the spore strip to vessels ofculture meedia. if spore suspensions were used, aseptically transferthe inoculated bottles to a laminar air flow work station $ addculture media to the bottles. use approximate possitive $ negativecontrols

4. Determine the no. of survivors by plate counting or fractionnegative methods.

References: [11]

Page 19: Presentation  of industrial pharmacy 2

Validation of ethylene oxide sterilization cycles

Eto has been a sterilant for over 50 years.

• 5 variables critical to the Eto process. they are

1. Eto concentration

2. Relative humidity

3. Temperature

4. Time

5. Pressure/vaccume.

temp is the easiest variable to measure $ monitor, therefore temp is used as the indicator of the worst-case location within the loaded Eto strilizer. Once the worst case location is identified, the validation studies are conducted with the goal of inactivating a known conc of indicator mo’s in the worst-case location using a specific loading pattern with a specific Eto cycles.

References: [15]

Page 20: Presentation  of industrial pharmacy 2

Procedure for the Eto cycle validation 1. Use a laboratory sized Eto sterilizer during early phases of the

validation process as long as the sterilizer is equipped withdevices allowing variability in vaccume ,relative humidity, temp,gas pressure, timing,$ rate of gassing the chamber.

2. Verify the calibration of all instrumentation involved inmonitoring the Eto cycle.

3. Perform an extensive temp distribution study using an emptysterilizer.

4. Do a series of repetitive runs for each sterilization cycle in anempty vessel in order to verify the accuracy and reliability of thesterilizer contorls and monitoring equipment.

5. Do a series of repetitive heat distribution and heat penetrationruns using a loaded Eto sterilizer.

Page 21: Presentation  of industrial pharmacy 2

7.Test should be conducted on the final packaged product.

8.Institute a documented monitoring system primary relying on bio-logical indicators,with lesser reliance on end-product sterility testing.

References: [15]

Page 22: Presentation  of industrial pharmacy 2

Validation of radiation sterilization process• The major objective in validating a radiation sterilization

process regardless of whether the mode of radiation iscobalt-60,cesium-137 or electron beam.

• The radiation sterilization cycles are validated based uponthe achievement of sterility ,many factors must beconsidered in the utilization and approval of the radiationsterilization process. such factors include

The physical appearance of the container system and itscontents,

Stability of the active ingradient, if present, and Safety of the irradiated material.

References: [16]

Page 23: Presentation  of industrial pharmacy 2

VALIDATION OF WATER SUPPLY SYSTEMS

Page 24: Presentation  of industrial pharmacy 2

OBJECTIVE

To understand:

1. The need for water quality manual

2. reason for usage of pharmaceutical water supply systems.

3. The technical requirements for water supply systems.

4. Different types of water supply systems.

5. Validation requirements.

6. Qualification & inspection requirement

References: [17]

24

Page 25: Presentation  of industrial pharmacy 2

INTRODUCTION

High-quality water is essential for the manufacturing of

pharmaceuticals. Water is the most commonly used raw

material in pharmaceutical manufacturing.

water is directly or indirectly used in the

pharmaceutical manufacturing such as a major

component in injectable products and in cleaning of

manufacturing equipment.

It is one of the raw material that is usually processed by

the pharmaceutical manufacturer prior to use because it

cannot be supplied by the vendor.

Water is thus an important raw material in GMP and in

validating the manufacturing process.

References: [17] 25

Page 26: Presentation  of industrial pharmacy 2

INTRODUCTIONQuality of water should be specific for product quality.

Water contains,

• Organic and inorganic impurities

• Microbial contamination

• Endotoxin

• Particulate contamination

Low quality of water can lead to

product degradation

product contamination

loss of product and profit

26

References: [17]

Page 27: Presentation  of industrial pharmacy 2

TYPES OF WATER Different grades of Water for Pharmaceutical Purposes-

each type has its on characteristic for all parameters.

Potable water

Purified water

Water for injection(WFI)

Sterile water for injection, inhalation, irrigation

Sterile bacteriostatic water for injection

References: [18]

27

Page 28: Presentation  of industrial pharmacy 2

References: [18]

Page 29: Presentation  of industrial pharmacy 2

DIFFERENT TECHNIQUES USED FOR WATER TREATMENT

– De-chlorination (Sodium Bisulphite, Carbon Filter)

– Filtration

– Ultra Filtration

– Softening

– Demineralization

– Reverse Osmosis

– UV Treatment

– Deionization

– Ozonization

References: [18]29

Page 30: Presentation  of industrial pharmacy 2

DIFFERENT EQUIPMENTS AND COMPONENTS FOR WATER SYSTEM

• Piping

• Valves

• Pumps

• Pressure gauges

• Heat exchangers

• Distillation unit

• Filters

• Deionizers

• Sensors

• Auxiliary equipment

References: [19]

Page 31: Presentation  of industrial pharmacy 2

WATER STORAGE AND DISTRIBUTION – CONSIDERATIONS– Materials of Construction (Chemical and Heat

Compatibility)• Stainless Steel (316 or 316L)• Teflon, Silicone, Viton (gaskets, diaphragms)

– Minimize Dead Legs (<= 2 pipe diameters)

– Smooth Surfaces (Mechanical Polish , Electropolish)

– Clean joints (sanitary Tri®Clamp, automatic orbitalwelding)

– Passivate interior surfaces to form barrier between waterand free iron (0.5 to 1% alkali at 160ºF for 30 minutesfollowed by 1% Phosphoric Acid or Nitric Acid at 150ºFto 180º F for 10 minutes.)

References: [19] 31

Page 32: Presentation  of industrial pharmacy 2

Conti….• Design of the following should be appropriate to prevent

recontamination after treatment-

–Vent filter

–Sanitary overflow

–Tank UV light

–Conical Bottom

–Steam sterilization

• Combination of on-line (TOC, Conductivity meter etc.) andoff-line monitoring (lab testing by proper sampling) to ensurecompliance with water specification

32References: [19]

Page 33: Presentation  of industrial pharmacy 2

VALIDATION CONCEPT To prove the performance of processes or systems under

all conditions expected to be encountered during future

operations.

To prove the performance, one must demonstrate

(document) that the processes or systems consistently

produce the specified quantity and quality of water when

operated and maintained according to specific written

operating and maintenance procedures.

validation involves proving-

1. Engineering design

2.Operating procedures and acceptable ranges for control

parameters

3. Maintenance procedures to accomplish itReferences: [17]

33

Page 34: Presentation  of industrial pharmacy 2

Conti..

• the system must be carefully,

-designed

-installed

-tested during processing, after construction, and

under all operating conditions.

• Variations in daily, weekly and annual system usage

patterns must be validated.

References: [17]34

Page 35: Presentation  of industrial pharmacy 2

STEPS OF VALIDATION

• Establishing standards for quality attributes

• Defining system and subsystem

• Designing equipment, control, & monitoringtechnologies

• Establishing standards for operating parameters

• Developing an IQ stage & OQ stage

• Establishing alert and action levels

• Developing a prospective PQ stage

• Completing protocols and documenting each steps

References: [17]

35

Page 36: Presentation  of industrial pharmacy 2

Conti…

36

Page 37: Presentation  of industrial pharmacy 2

DESIGN QUALIFICATION OF WATER SYSTEMBased on the URS, supplier designs the equipment.

• This is 1st step in the qualification of new water supply systems.

• Define process schematically by use of PFD and P&IDs.

• It is documented the design of the system & will include :

-Functional Specification.(Storage, purification, etc)

-Technical/Performance specification for equipment.(requirements of water volume and flow, define pumps and pipe sizes )

-Detailed layout of the system.

Design must be in compliance with GMPs and other regulatoryrequirements.

References: [18]

37

Page 38: Presentation  of industrial pharmacy 2

REFERENCES1. Mascoli , C,C should end product sterility testing continue,

med dev Diag ind 3: 8-9(1981)

2. Bowman. F.W.the sterility testing of pharmaceuticals. j. pharm sci 58:1301-1308(1969)

3. Ernst R.R., West, K.L.Doyle, J.E.problemareas in sterility testing .Bull parenter drug assoc 23:29-39(1969)

4. Akers ,M.J. In : parenteral quality control :sterility , pyrogen,particulate matter, and package integrity testing, 2nd

addition . Newyork: Marcel Dekker ,pp.1-4 (1994)

5. Brewer , J.H. In: G.L. Redish , ed. Anticeptics, disinifectants, fungicides, and sterilization , 2nd ed. Philadelphia: Lea $ Febiger,pp,160-161(1957)

6. Food $ drug administration. Guidelines on general principles of process validation. Rockville , MD:FDA(1984)

Page 39: Presentation  of industrial pharmacy 2

7. Reich, R.R.,Whibourne, J.E.,Mcdaniel, A.W.effect of storage conditions on the performance of B.steaothermophilus biological indicators.

8.validation of steam sterilization cycles .technical monograph no.1 parenteral drug association (1978) .

9.Tsuji,K.harrison,S.J.dry-heat destroction of lipopolysaccharide : dry heat destruction kinetics.

10.pflug .I.J. holcomb .R.J principles of thermal destruction of mo’s.

11.validation of dry heat sterilization used for sterilization and depyrogenation, technical no.3parenteral drug administration(1981)

12.simmons,P.L.validation of dry heat sterilizer.pharm eng 38(may- july 1981).

Page 40: Presentation  of industrial pharmacy 2

13.simmons,P.L.Hot air and continuous sterilization.akers,M.J.,Ketron,K.,Thompson. B.F.value requirements for the destruction of endotoxin

in the validation of dry heat sterilization cycles.14.Avis,K.E.jewell,ludwig,J.D.avis,K.E.validation of a heating cellfor

precisely controlled studies on the thermal destruction of endotoxin inglass.

15.Robertson,J.H.,Townsend.M.W,Allen;valenti,simmons,P.L.ETO

sterilization,caputo,R.A.Rohn.

16.ISO11137:1995.sterilization of health care products –requirements forvalidation $ routine control –radiation sterilization .

17. ICH.GMP guide for active pharmaceutical ingredients.Q7A(march

15,2000).

18.general information:water for pharmaceutical

purposes.U.S.pharmacopeia.vol.25.rockville,MD:U.S.pharmacopeial

convention,pp.2261-2270(2002).

19.Pharmaceutical engineering guide vol.4:water $ steam guide. tampa,

FL:ISPE, (1997).

Page 41: Presentation  of industrial pharmacy 2

41

THANK

YOU